Logo

Nycomed Rethinks Plans for Amersham Unit

Jun 30, 2000
Premium

Anglo-Norwegian healthcare group Nycomed is evaluating the structure of its Amersham Pharmacia Biotech unit, which is 45 percent owned by Pharmacia, Reuters reported.

 

According to the report, Nycomed CEO Bill Castell said that the company was considering increasing its stake in APB as well as floating the unit

 

An announcement on the new structure is expected soon.

 

Meanwhile, APB said it will create about 200 new jobs, which will nearly double its workforce to 475 employees.

 

Most of the job openings will be in research and development at the company’s recently unveiled genomics center at its Silicon Valley-based subsidiary, Molecular Dynamics in Sunnyvale, Calif.

 

Filed under

Informatics
Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.